| Followers | 11 |
| Posts | 1963 |
| Boards Moderated | 0 |
| Alias Born | 04/16/2024 |
Thursday, July 04, 2024 12:29:44 PM
I wonder... when will people realize that the AAV stuff is great... CADL, SLDB, PASG
The founder certainly thinks so... and he is the authority on the topic:
"Dr. James M. Wilson serves as the Director of the Gene Therapy Program (GTP) at Penn's Perelman School of Medicine."
"The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy."
The founder certainly thinks so... and he is the authority on the topic:
"Dr. James M. Wilson serves as the Director of the Gene Therapy Program (GTP) at Penn's Perelman School of Medicine."
"The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy."
Recent PASG News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 08:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/26/2026 11:15:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:14:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 11:01:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:00:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 11:15:35 AM
- Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates • GlobeNewswire Inc. • 04/20/2026 11:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/07/2026 11:02:54 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/07/2026 11:01:25 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/07/2026 11:00:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:07:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 11:15:33 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/04/2026 09:05:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/03/2026 12:15:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 12:00:21 PM
- Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Passage Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/19/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 09:03:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 09:03:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 12:01:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/09/2026 09:03:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 09:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:15:44 PM
- Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 11/10/2025 09:15:00 PM
